ArticleSpringerPlus2015
Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.
Article in SpringerPlus, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin.Scientific reports · 2019Trial
- A Comprehensive Review of the Clinical Utility and Reliability of a Quantitative Electrical Stimulation Device for Objective Pain Assessment.Journal of pain research · 2026Review
- The effect of corrective exercises on musculoskeletal disorders among the older adults residing in a nursing home in Rasht, Guilan, Iran.BMC musculoskeletal disorders · 2023Article
- A Quantitative Measure of Pain with Current Perception Threshold, Pain Equivalent Current, and Quantified Pain Degree: A Retrospective Study.Journal of clinical medicine · 2023Article
- PainVision-based evaluation of brain potentials: a novel approach for quantitative pain assessment.Frontiers in bioengineering and biotechnology · 2023Article
- Analgesia by Sacral Surface Electrical Stimulation for Primary Dysmenorrhoea.Journal of rehabilitation medicine. Clinical communications · 2020Article
- The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy.Scientific reports · 2019Article
- Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration.SpringerPlus · 2016Article
- Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing pain.Multiple sclerosis journal - experimental, translational and clinicalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numbness and pain are currently evaluated using subjective methods such as the visual analog scale (VAS). However, because assessment of pain can vary greatly depending on the mood and physical state of the patient at the time of assessment, it is best to evaluate pain objectively. pain vision PS-2100 (PV) is an analytical instrument that was designed to quantitatively and objectively assess sense perception and nociception in patients. The present study examined the correlation of subjective and objective assessment of oxaliplatin-induced peripheral neuropathy (PN) using VAS and PV, respectively. The mean VAS and PV scores of PN were 20.5 (range 0-100) and 27.9 (range 0-416), respectively. The partial correlation coefficient was 0.274 (p = 0.0003). No strong correlation was observed between the results and a weak correlation was observed between VAS and PV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.